Published on 3 May 2024 on Zacks via Yahoo Finance
Why Intellia Therapeutics, Inc. (NTLA) Outpaced the Stock Market Today
The most recent trading session ended with Intellia Therapeutics, Inc. (NTLA) standing at $23.60, reflecting a +1.42% shift from the previouse trading day's closing. This change outpaced the S&P 500's 1.26% gain on the day. On the other hand, the Dow registered a gain of 1.18%, and the technology-centric Nasdaq increased by 1.99%.
The the stock of company has fallen by 6.81% in the past month, lagging the Medical sector's loss of 1.54% and the S&P 500's loss of 2.68%.